Featured Research

from universities, journals, and other organizations

UCLA Study Shows Early Brain Function Decline In Individuals With Alzheimer's Disease Gene

Date:
May 23, 2000
Source:
University Of California Los Angeles
Summary:
UCLA researchers have found that adults carrying an Alzheimer's disease gene show significant decline in brain function over a two-year period - without symptoms of the disease. These new findings may lead to novel treatments to help prevent and delay the onset of Alzheimer's, a fatal disease currently affecting four million Americans.

UCLA researchers have found that adults carrying an Alzheimer's disease gene show significant decline in brain function over a two-year period - without symptoms of the disease. These new findings may lead to novel treatments to help prevent and delay the onset of Alzheimer's, a fatal disease currently affecting four million Americans.

Related Articles


The study, appearing this week in the Proceedings of the National Academy of Sciences, combined genetic testing with positron emission tomography (PET) scanning to determine brain function in people at risk for Alzheimer's disease who still had normal memory function.

"This method may provide an effective way to detect Alzheimer's disease preclinically and test preventive therapies before permanent brain damage becomes extensive," said Dr. Gary Small, lead investigator and the Parlow-Solomon Professor on Aging and professor of psychiatry and biobehavioral sciences at UCLA.

UCLA researchers performed genetic testing on 54 adults, aged 50-84, with very mild and common age-related memory complaints. Half of the participants carried the apolipoprotein E-4 allele or APOE-4, a gene associated with Alzheimer's disease.

Each study participant received PET scans, a relatively new technology developed at UCLA. PET scans measure brain activity by revealing the amount of glucose metabolized throughout the brain. Unlike other brain imaging techniques, PET scans can differentiate Alzheimer's disease from the normal effects of aging.

Initial PET scans revealed that the group carrying the Alzheimer's gene had significantly lower function in the parietal and temporal regions of the brain, compared with the group without the APOE-4 gene. The temporal region is located at the temples and the parietal region is located above and behind the temples.

UCLA researchers conducted a two-year follow-up on 20 study participants. The group carrying the APOE-4 gene demonstrated a 5 percent function decline in these same two regions of the brain compared with their initial PET scans.

The group without the Alzheimer's gene demonstrated decline only in the frontal cortex, located in the front of the brain, which is consistent with normal aging. Results of memory testing, when researchers ask questions to measure forgetfulness and changes in memory, appeared normal for both groups at the beginning of the study and at the two-year follow-up.

"These findings indicate that brain function decline may begin to occur in the brain in individuals with APOE-4 long before the actual physical symptoms of Alzheimer's disease appear," said Small. "We found that a single copy of the APOE-4 gene was associated with lowered brain function in people with normal memory performance."

According to Small, the UCLA study is the first to report long-term PET results for individuals with the genetic risk for Alzheimer's who have no disease symptoms.

"We are now in a position to use these genetic and brain imaging tools to determine if we can prevent age-related memory decline and delay the onset of Alzheimer's disease," said Small.

"The UCLA study provides an important step in offering hope that we will eventually have an impact on Alzheimer's disease through prevention," said Dr. Barry Lebowitz, chief of the Adult/Geriatric Treatment and Prevention Research at the National Institute of Mental Health.

The UCLA research team has just announced a new UCLA Memory Clinic for testing treatments to prevent age-related memory loss. Studies will continue research into exploring the use of PET scanning and genetic testing.

The UCLA study was a collaborative effort between the UCLA Neuropsychiatric Institute, the UCLA Department of Molecular and Medical Pharmacology, the UCLA Brain Mapping Center, the UCLA Center on Aging, the UCLA Alzheimer's Disease Center, and the Center for Human Genetics at Duke University Medical Center.

Alzheimer's disease afflicts nearly 10 percent of people over age 65. The disease often begins with mild memory complaints and gradually progresses to dementia, which is a deterioration of most mental abilities including memory, language and higher intellectual functions. Victims eventually become bedridden, requiring total care.

The United States annually spends approximately $100 billion on Alzheimer's. Experts estimate that delaying the disease onset by five years could save $50 billion and reduce the expected number of cases by a million during the next decade.

The UCLA study was supported by grants from the National Institute on Mental Health, the National Institute of Aging, the Alzheimer's Association, the California Department of Health Services, the Department of Energy, the Sidell-Kagen Foundation, the Montgomery Street Foundation, the Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research, the Brain Mapping Medical Research Organization, the Ahmanson Foundation, and the Tamkin Foundation.


Story Source:

The above story is based on materials provided by University Of California Los Angeles. Note: Materials may be edited for content and length.


Cite This Page:

University Of California Los Angeles. "UCLA Study Shows Early Brain Function Decline In Individuals With Alzheimer's Disease Gene." ScienceDaily. ScienceDaily, 23 May 2000. <www.sciencedaily.com/releases/2000/05/000522082229.htm>.
University Of California Los Angeles. (2000, May 23). UCLA Study Shows Early Brain Function Decline In Individuals With Alzheimer's Disease Gene. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2000/05/000522082229.htm
University Of California Los Angeles. "UCLA Study Shows Early Brain Function Decline In Individuals With Alzheimer's Disease Gene." ScienceDaily. www.sciencedaily.com/releases/2000/05/000522082229.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins